Correlation Between Oric Pharmaceuticals and Elicio Therapeutics

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and Elicio Therapeutics, you can compare the effects of market volatilities on Oric Pharmaceuticals and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Elicio Therapeutics.

Diversification Opportunities for Oric Pharmaceuticals and Elicio Therapeutics

0.01

Correlation Coefficient

Oric Pharmaceuticals  Elicio Therapeutics

Significant diversification

The 3 months correlation between Oric and Elicio is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and Elicio Therapeutics

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the Elicio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Oric Pharmaceuticals is 1.12 times less risky than Elicio Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Elicio Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  498.00  in Elicio Therapeutics on September 23, 2024 and sell it today you would lose (10.00) from holding Elicio Therapeutics or give up 2.01% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Oric Pharmaceuticals  vs.  Elicio Therapeutics

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Elicio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elicio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Elicio Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Oric Pharmaceuticals and Elicio Therapeutics

The main advantage of trading using opposite Oric Pharmaceuticals and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.

The idea behind Oric Pharmaceuticals and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.